IP Library Assignment 051297/0178
Patent Assignment
Reel/Frame 051297/0178

Assignment of Assignor's Interest

Recorded: 2019-12-16 Pages: 10
Assignor
CIPHER PHARMACEUTICALS INC.
Executed: 2019-10-10
Assignee
ASTION PHARMA A/S
TRAEVAENGET 14, VISSENBJERG, 5492, DENMARK
Covered Properties (3)
Treatment of Connective Tissue Diseases of the Skin
Patent: 8,426,475 →
Application: 11/402,255 →
Publication: US 2006/0235048
Treatment of Connective Tissue Diseases of the Skin
Patent: 9,907,765 →
Application: 15/440,803 →
Publication: US 2017/0157068
Treatment of Connective Tissue Diseases of the Skin
Application: 16/228,920 →
Publication: US 2019/0125699
Related Assignments (10)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 20, 2006
From: WEIDNER, MORTEN SLOTH
To: ASTION DEVELOPMENT A/S
Reel/Frame 017995/0734 →
Assignment of Assignor's Interest Nov 25, 2008
From: WULF, HANS CHRISTIAN
To: ASTION DEVELOPMENT A/S
Reel/Frame 021891/0538 →
Assignment of Assignor's Interest Mar 3, 2015
From: ASTION PHARMA A/S
To: AP NEWCO A/S
Reel/Frame 035078/0975 →
Assignment of Assignor's Interest Mar 3, 2015
From: ASTION PHARMA A/S
To: CIPHER PHARMACEUTICALS INC.
Reel/Frame 035079/0305 →
Assignment of Assignor's Interest Mar 3, 2015
From: ASTION DERMATOLOGY A/S
To: ASTION PHARMA A/S
Reel/Frame 035078/0524 →
Change of Name Mar 3, 2015
From: AP NEWCO A/S
To: ASTION PHARMA A/S
Reel/Frame 035119/0463 →
Security Agreement Apr 14, 2015
From: CIPHER PHARMACEUTICALS INC.
To: ATHYRIUM OPPRTUNITIES II ACQUISITION LP
Reel/Frame 035424/0227 →
Asset Purchase Agreement Jul 11, 2016
From: ASTION PHARMA A/S
To: CIPHER PHARMACEUTICALS INC.
Reel/Frame 039301/0307 →
Assignment of Assignor's Interest May 24, 2017
From: ASTION DEVELOPMENT A/S
To: ASTION PHARMA A/S
Reel/Frame 042551/0926 →
Release of Security Interest Nov 9, 2017
From: ATHYRIUM OPPORTUNITIES II ACQUISITION LP, AS COLLATERAL AGENT (BY ITS GENERAL PARTNERS: ATHYRIUM OPPORTUNITIES ASSOCIATES II LP AND ATHYRIUM GP HOLDING LLC )
To: CIPHER PHARMACEUTICALS INC.
Reel/Frame 044084/0426 →